Chronic plaque psoriasis. Psoriasis
Conditions
Interventions
Intervention 1: Intervention group 1: Patients will receive the prepared cream containing 5% caffeine along with fluocinolone acetonide 0.025%. The creams are distributed in divided doses at the begin
Sponsors
Tabriz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
7 Years to 70 Years
Inclusion criteria
Inclusion criteria: Patient age over 7 years No history of immunosuppression or iatrogenic Not using medication or treatment methods to treat psoriasis in the two weeks before the study No history of caffeine allergy Not pregnant or currently breastfeeding Consent to participate in the study
Exclusion criteria
Exclusion criteria: Pregnant or lactating women Aggravation of the disease during the study Joint involvement during the study that requires oral treatment Sensitization while using the drug during the study (such as vesicular rash, erythema, itching, etc.)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The rate of recovery of lesions. Timepoint: Patients will be evaluated at the beginning of the study and at weekly intervals for three consecutive weeks. Method of measurement: Psoriasis area and severity index. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Hamideh Herizchi Ghadim
Tabriz University of Medical Sciences
Outcome results
None listed